Interim Results from the PRISM Phase 1/2 Clinical Trial Evaluating Intravitreal 4D-150 in Adults with Neovascular Age-Related Macular DegenerationSeptember 13, 2024/in Scientific Presentation/by Erik Allison /wp-content/uploads/4dmt_logo.svg 0 0 Erik Allison /wp-content/uploads/4dmt_logo.svg Erik Allison2024-09-13 14:59:402024-09-13 15:59:49Interim Results from the PRISM Phase 1/2 Clinical Trial Evaluating Intravitreal 4D-150 in Adults with Neovascular Age-Related Macular Degeneration